4//SEC Filing
Larkin Finbar 4
Accession 0001765581-20-000022
CIK 0001232524other
Filed
Mar 1, 7:00 PM ET
Accepted
Mar 2, 6:35 PM ET
Size
7.7 KB
Accession
0001765581-20-000022
Insider Transaction Report
Form 4
Larkin Finbar
SVP, Technical Development
Transactions
- Award
Non-Qualified Stock Option (right to buy)
2020-02-27+12,500→ 12,500 totalExercise: $113.10Exp: 2030-02-26→ Ordinary Shares (12,500 underlying) - Award
Ordinary Shares
2020-02-27+5,000→ 15,069 total
Footnotes (3)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of March 5, 2020, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.
- [F2]Includes 81 ordinary shares acquired under a Section 423 Employee Stock Purchase Plan on November 29, 2019.
- [F3]These options are granted pursuant to the Issuer's 2011 Equity Incentive Plan. The ordinary shares subject to these options vest over four years measured from the grant date, February 27, 2020, with 1/4th vesting on the first anniversary of the grant date and the remainder vesting in 36 equal monthly installments thereafter.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001793243
Filing Metadata
- Form type
- 4
- Filed
- Mar 1, 7:00 PM ET
- Accepted
- Mar 2, 6:35 PM ET
- Size
- 7.7 KB